Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emerpharma is a Spanish pharmaceutical company founded in 2011 and headquartered in Madrid. The company specializes in the commercialization and distribution of medicines, medical devices, and food supplements across Spain and Portugal. Its portfolio focuses on several therapeutic areas, including the central nervous system, respiratory health, gynecology, and pediatrics. Emerpharma operates as a specialty pharmaceutical entity, bridging the gap between drug development and market access in the Iberian Peninsula. The company is known for its range of nutritional supplements and over-the-counter products, such as the Emer-D3 and Emer-B12 lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMERpharma.